Nagehan Emiralioglu

Nagehan Emiralioglu

Auto-generated profile, based on publicly available information

Nagehan Emiralioglu

Division of Pulmonology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2024 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
JRJohanna Raidt
Johanna Raidt
SRSarah Riepenhausen
Sarah Riepenhausen
PPPetra Pennekamp
Petra Pennekamp
HOHeike Olbrich
Heike Olbrich
Israel AmiravIsrael Amirav
Israel Amirav
HOHeymut Omran
Heymut Omran
Background: Primary ciliary dyskinesia (PCD) represents a group of rare hereditary disorders characterised by deficient ciliary airway clearance that can be associated with laterality defects. We aimed to describe the underlying gene defects, geographical differences in genotypes and their relationship to diagnostic findings and clinical phenotypes.Methods: Genetic variants and clinical findings (age, sex, body mass index, laterality defects, forced expiratory volume in 1 s (FEV1)) were collected from 19 countries using the European Reference Network's ERN-LUNG international PCD Registry. Genetic data were evaluated according to American College of Medical Genetics and Genomics guidelines. We assessed regional distribution of implicated genes and genetic variants as well as genotype correlations with laterality defects and FEV1.Results: The study included 1236 individuals carrying 908 distinct pathogenic DNA variants in 46 PCD genes. We found considerable variation in the distribution of PCD genotypes across countries due to the presence of distinct founder variants. The prevalence of PCD genotypes associated with pathognomonic ultrastructural defects (mean 72%, range 47–100%) and laterality defects (mean 42%, range 28–69%) varied widely among countries. The prevalence of laterality defects was significantly lower in PCD individuals without pathognomonic ciliary ultrastructure defects (18%). The PCD cohort had a reduced median FEV1z-score (−1.66). Median FEV1z-scores were significantly lower inCCNO(−3.26),CCDC39(−2.49) andCCDC40(−2.96) variant groups, while the FEV1z-score reductions were significantly milder inDNAH11(−0.83) andODAD1(−0.85) variant groups compared to the whole PCD cohort.Conclusion: This unprecedented multinational dataset of DNA variants and information on their distribution across countries facilitates interpretation of the genetic epidemiology of PCD and indicates that the genetic variant can predict diagnostic and phenotypic features such as the course of lung function.

21 February 2023 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
NNNadia Nathan
Nadia Nathan
MGMatthias Griese
Matthias Griese
KMKatarzyna Michel
Katarzyna Michel
JCJulia Carlens
Julia Carlens
CGCarlee Gilbert
Carlee Gilbert
RERalph Epaud
Ralph Epaud
Childhood interstitial lung diseases (chILDs) are rare and heterogeneous diseases with significant morbidity and mortality. An accurate and quick aetiological diagnosis may contribute to better management and personalised treatment. On behalf of the European Respiratory Society Clinical Research Collaboration for chILD (ERS CRC chILD-EU), this review summarises the roles of the general paediatrician, paediatric pulmonologists and expert centres in the complex diagnostic workup. Each patient's aetiological chILD diagnosis must be reached without prolonged delays in a stepwise approach from medical history, signs, symptoms, clinical tests and imaging, to advanced genetic analysis and specialised procedures including bronchoalveolar lavage and biopsy, if necessary. Finally, as medical progress is fast, the need to revisit a diagnosis of “undefined chILD” is stressed.

25 November 2019 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
NENagehan Emiralioğlu
Nagehan Emiralioğlu
ETEkim Z. Taşkıran
Ekim Z. Taşkıran
CKCan Koşukcu
Can Koşukcu
EBElif Bilgiç
Elif Bilgiç
PAPERGIN ATILLA
PERGIN ATILLA
UÖUğur Özçelik
Uğur Özçelik

18 September 2020 in Pediatric Pulmonology
Verified
Journal Article
Open access
PDF file
DTDilber Ademhan Tural
Dilber Ademhan Tural
NENagehan Emiralioglu
Nagehan Emiralioglu
SHSelma Tural Hesapcioglu
Selma Tural Hesapcioglu
SKSevilay Karahan
Sevilay Karahan
BÖBeste Özsezen
Beste Özsezen
NKNural Kiper
Nural Kiper
Background: We aim to assess the anxiety and depressive symptoms related to the COVID‐19 pandemic in children with chronic lung disease and their parents and also to evaluate parents' coping strategies.Methods: Parents of children aged 4–18 years, with chronic lung disease (study group n = 113) and healthy control (n = 108) were enrolled in the study. General Health Questionnaire‐12, specific COVID‐19 related anxiety questions, The Coping Orientation to Problems Experienced inventory, coronavirus‐related psychiatric symptom scale in children–parental form were used to analyze the psychiatric effects of COVID‐19. Parents were also asked about how online education affected their family life and children. All data were compared between children/parents in the study and control groups. Risk factors related with anxiety scores of children were also analyzed.Results: Talking about the pandemic, concern about coronavirus transmission, taking precaution to prevent coronavirus transmission, making pressure to protect from COVID‐19 were significantly higher in parents within the study group (p < .05). Parents in the study group used more problem‐focused coping than parents in the control group (p = .003). Anxiety symptoms score was higher in children of the study group (p = .007). Parents in the study group found online education more useful than parents in the control group.Conclusion: Children with chronic lung diseases and their parents have more anxiety due to COVID‐19 pandemic and these parents use more mature coping strategies to manage the stress of the pandemic. Longitudinal and larger studies should be done in all aspects of online education in children with chronic lung diseases.

11 November 2019 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
DDDeniz Dogru
Deniz Dogru
ECErkan Cakir
Erkan Cakir
AAAyse Tana Aslan
Ayse Tana Aslan
Nazan CobanogluNazan Cobanoglu
Nazan Cobanoglu
SPSevgi Pekcan
Sevgi Pekcan
UÖUğur Özçelik
Uğur Özçelik

20 October 2022 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
FHFlorian S. Halbeisen
Florian S. Halbeisen
EPEva Sophie Lunde Pedersen
Eva Sophie Lunde Pedersen
MGMyrofora Goutaki
Myrofora Goutaki
BSBen D. Spycher
Ben D. Spycher
Israel AmiravIsrael Amirav
Israel Amirav
CKClaudia E. Kuehni
Claudia E. Kuehni
Primary ciliary dyskinesia (PCD) presents with symptoms early in life and the disease course may be progressive, but longitudinal data on lung function are scarce. This multinational cohort study describes lung function trajectories in children, adolescents and young adults with PCD. We analysed data from 486 patients with repeated lung function measurements obtained between the age of 6 and 24 years from the International PCD Cohort and calculated z-scores for forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio using the Global Lung Function Initiative 2012 references. We described baseline lung function and change of lung function over time and described their associations with possible determinants in mixed-effects linear regression models. Overall, FEV1, FVC and FEV1/FVC z-scores declined over time (average crude annual FEV1decline was −0.07 z-scores), but not at the same rate for all patients. FEV1z-scores improved over time in 21% of patients, remained stable in 40% and declined in 39%. Low body mass index was associated with poor baseline lung function and with further decline. Results differed by country and ultrastructural defect, but we found no evidence of differences by sex, calendar year of diagnosis, age at diagnosis, diagnostic certainty or laterality defect. Our study shows that on average lung function in PCD declines throughout the entire period of lung growth, from childhood to young adult age, even among patients treated in specialised centres. It is essential to develop strategies to reverse this tendency and improve prognosis.